Filing Details
- Accession Number:
- 0001179110-13-017896
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-13 16:55:07
- Reporting Period:
- 2013-12-11
- Filing Date:
- 2013-12-13
- Accepted Time:
- 2013-12-13 16:55:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145460 | Alere Inc. | ALR | In Vitro & In Vivo Diagnostic Substances (2835) | 043565120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1571532 | Kate Torchilin | 51 Sawyer Road, Suite 200 Waltham MA 02453 | Vp, Connected Health | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-11 | 10,000 | $26.06 | 10,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-11 | 7,972 | $33.73 | 2,028 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-12-11 | 675 | $25.43 | 2,703 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-11 | 575 | $33.73 | 2,128 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-12-11 | 10,000 | $0.00 | 10,000 | $26.06 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2013-12-11 | 675 | $0.00 | 675 | $25.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-10-31 | No | 4 | M | Direct | |
0 | 2022-02-28 | No | 4 | M | Direct |
Footnotes
- This price represents the average purchase price for 28 separate transactions reported on this line. The price of the transactions reported on this line range from $33.70 to $33.78. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.
- These options became exercisable in four equal annual installments beginning 10/31/2012.
- These options became exercisable in four equal annual installments beginning 2/28/2013.
- This derivative security does not have a price.
- Represents sell to cover exercise of stock options.